Fermentation of Structurally Defined Alginate Oligosaccharides by the Human Gut Microbiota Enriched in Bifidobacterium, Bacteroides, Faecalibacterium, or Blautia
Marine Drugs · 07.07.2026 · 24 (7) · 239
DOI: 10.3390/md24070239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 07.07.2026. Verfasst von Siyu Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs of Ministry of Education, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharma…. Hauptthemen laut MEDLINE: Alginates, Oligosaccharides, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key R&D Program of Shandong Province, Key R&D Program of Shandong Province.
Abstract (Originalsprache)
Alginate oligosaccharides (AOS) are attractive candidates for prebiotic development, yet how oligosaccharide structure and baseline microbial community composition interact to shape fermentation remains an open question. In this study, we stratified fecal microbiota from healthy donors into operational genus-predominance groups (Bifidobacterium, Bacteroides, Faecalibacterium, or Blautia) and selected representative samples for in vitro fermentation of six structurally distinct AOS preparations (SAOS-1, SAOS-2, OAOS, UAOS, SMOS, and SGOS). Substrate consumption, short-chain fatty acid (SCFA) production, and shifts in microbial community structure were profiled. The six preparations differed in structural type, number-average molecular weight, and average degree of polymerization. Among them, SAOS-1 exhibited the most consistent utilization across all four groups and yielded the highest total SCFA production. SAOS-1 fermentation also attenuated inter-group community divergence and enriched several beneficial or functionally relevant taxa, including Bacteroides and Faecalibacterium. Interestingly, the magnitude and direction of microbial responses remained enterotype-dependent, with the Bacteroides-predominant group assembling the most complex fermentative consortium. These findings demonstrate that AOS structure and baseline microbial ecology jointly dictate fermentation outcomes, positioning SAOS-1 as a strong candidate for precision prebiotic development. This structure–community interaction paradigm provides a rational basis for the targeted deployment of marine oligosaccharides in personalized gut health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs of Ministry of Education, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China.
- Marine Biomedical Research Institute of Qingdao, Qingdao 266071, China.
ORCID-Profile: Meng Shao, Quancai Li, Qingsen Shang
Förderung
- National Natural Science Foundation of China
- Key R&D Program of Shandong Province
- Key R&D Program of Shandong Province
Zitieren
APA
Liu, S., Wu, Y., Lv, Y., Shao, M., Lv, D., Li, Q., & Shang, Q. (2026). Fermentation of Structurally Defined Alginate Oligosaccharides by the Human Gut Microbiota Enriched in Bifidobacterium, Bacteroides, Faecalibacterium, or Blautia. Marine Drugs, 24(7), 239. https://doi.org/10.3390/md24070239
Vancouver
Liu S, Wu Y, Lv Y, Shao M, Lv D, Li Q, et al. Fermentation of Structurally Defined Alginate Oligosaccharides by the Human Gut Microbiota Enriched in Bifidobacterium, Bacteroides, Faecalibacterium, or Blautia. Marine Drugs. 2026;24(7):239. doi:10.3390/md24070239
BibTeX
@article{Liu2026,
author = {Liu, Siyu and Wu, Yuchen and Lv, Youjing and Shao, Meng and Lv, Depeng and Li, Quancai and Shang, Qingsen},
title = {Fermentation of Structurally Defined Alginate Oligosaccharides by the Human Gut Microbiota Enriched in Bifidobacterium, Bacteroides, Faecalibacterium, or Blautia},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {7},
pages = {239},
doi = {10.3390/md24070239}
}
EUVIMED